Delivra Health Brands Inc.
Delivra Health Brands Inc. (DHB.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dhb.v · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Delivra Health Brands Inc. (DHB.V) measures how much investors pay for each dollar of the company's trailing earnings. DHB.V's current PE ratio of N/A is calculated by dividing its stock price of $0.12 by its TTM earnings per share of -$0.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Delivra Health Brands Inc.You DHB.V | $4M | N/A | — | -$0.03 |
 Avant Brands Inc. AVNT.TO | $7M | N/A | — | -$0.88 |
 Blueberries Medical Corp. BBM.CN | $5M | N/A | — | -$0.00 |
 BetterLife Pharma Inc. BETR.CN | $11M | N/A | — | -$0.01 |
 Christina Lake Cannabis Corp. CLC.CN | $7M | 7.30x | — | $0.00 |
 CLS Holdings USA, Inc. CLSH.CN | $8M | N/A | — | -$0.05 |
 Crescita Therapeutics Inc. CTX.TO | $15M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.04 | — | |
2024-06-30 FY2024 | 9.78x | $0.03 | — | |
2023-06-30 FY2023 | — | $-0.01 | — | |
2022-06-30 FY2022 | — | $-0.28 | — | |
2021-06-30 FY2021 | — | $-1.00 | — | |
2020-06-30 FY2020 | — | $-2.66 | — | |
2019-06-30 FY2019 | — | $-1.45 | — | |
2018-06-30 FY2018 | — | $-1.05 | — | |
2017-06-30 FY2017 | — | $-1.57 | — | |
2016-06-30 FY2016 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Delivra Health Brands Inc. (DHB.V) measures how much investors pay for each dollar of the company's trailing earnings. DHB.V's current PE ratio of N/A is calculated by dividing its stock price of $0.12 by its TTM earnings per share of -$0.03.
Frequently asked questions
DHB.V pe ratio · 6 questionsDHB.V's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.12 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via DHB.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Delivra Health Brands Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08